FDA Inspection
GCAM IncGCAM Inc – FDA Inspection, Sep 16, 2019
Record Details
This FDA Inspection record concerns GCAM Inc, with an inspection on September 16, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7e3b6795-cd30-4b19-94ce-a6359c5cc50a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102522
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.15(b)(2)(iii)Donor consent clear
Full citation text and observation details available on the Dashboard.
Other FDA inspections of GCAM Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 11, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 25, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 4, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for GCAM Inc
- FDA Inspection 944048 - 2015-09-11
- FDA Inspection 787933 - 2012-06-25
- FDA Inspection 745694 - 2011-09-22
- FDA Inspection 677892 - 2010-08-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.